Variations in Cardiac Transplantation: Comparisons between the United Kingdom and the United States Ani C. Anyanwu, FRCS, Chris A. Rogers, PhD, and Andrew J. Murday, MA MS FRCS* Background: International practice variations have been documented in various health care specialties. This study compares cardiac transplantation in the UK with practice in the US. Methods: UK data were from an ongoing multi-center prospective study, the UK Cardiothoracic Transplant Audit. The UK population comprised 620 listings and 463 transplants. US data were obtained from UNOS and comprised 3946 listings and 4704 transplants. Results: There was a mean of 14 transplants per center per year in the US compared with 34 in the UK. Notable differences in practice include rarity of listing in the UK of patients  65 years (0.2% vs 4.1% in US) and patients with previous transplants (UK 0.9%, US 3.2%). Patients listed in the US were more likely to be on ventricular assist devices (odds ratio 8.0, 95% CI 3.0 –21.7) or inotropes (odds ratio 4.9, 95% CI 3.7– 6.4). Living donor (domino) transplants, although comprising 7% of transplants in the UK, are virtually non-existent in the US (1 domino in 4704 transplants). Heterotopic transplants were more common in the UK (4.4% vs 0.5%). Indications for transplant were similar (except retransplantation). The donor age was 35 years in 43% of UK donors vs 33% of US donors. Conclusion: This study reveals substantial practice differences between the UK and US. Further studies are required to examine the reasons for these practice differences, the inﬂuence on transplant outcome, and their ethical and economic implications. J Heart Lung Transplant 1999;18:297–303. In evaluating health care delivery, comparative studies are helpful in extending our knowledge and in identifying areas of practice or provision requir- ing modiﬁcation. Three fundamental issues under- pin efforts to reform health care systems— cost, quality and access. 1 In seeking to improve the national delivery of heart transplantation, these issues remain central. Although social, economic From the Surgical Epidemiology and Audit Unit, The Royal College of Surgeons of England, London, United Kingdom. Submitted April 10, 1998; accepted August 14, 1998. * For the Uk Cardiothoracic Transplant Audit SteeringGroup. Members of Steering Group and participating centers: Robert S. Bonser (Queen Elizabeth Hospital, Birmingham); John Dark (Freeman Hospital, Newcastle); Abdul K. Deiraniya (Wyth- enshawe Hospital, Manchester); Dr. Peter Doyle (Department of Health representative); Marc R. de Leval (Great Ormond Street Hospital for Children, London); Timothy J. Locke (Northern General Hospital, Shefﬁeld); Andrew J. Murday (St George’s Hospital, London); John Wallwork (Papworth Hos- pital, Cambridge); Prof. David J. Wheatley (Glasgow Royal Inﬁrmary, Glasgow); and Prof. Sir Magdi Yacoub (Hareﬁeld Hospital, Middlesex). Reprint requests: A. J. Murday, Director of Intrathoracic Trans- plantation, St. George’s Hospital, Blackshaw Road, London SW17 0QT, United Kingdom. Copyright © 1999 by the International Society for Heart and Lung Transplantation. 1053-2498/99/$–see front matter PII S1053-2498(98)00051-5 297